Astria Therapeutics (ATXS) Other Gross PP&E Adjustments: 2017-2019
Historic Other Gross PP&E Adjustments for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to -$1.4 million.
- Astria Therapeutics' Other Gross PP&E Adjustments fell 601.04% to -$1.4 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$2.0 million, marking a year-over-year decrease of 282.03%. This contributed to the annual value of -$16,000 for FY2018, which is 100.95% down from last year.
- As of Q3 2019, Astria Therapeutics' Other Gross PP&E Adjustments stood at -$1.4 million, which was down 364.95% from -$291,000 recorded in Q2 2019.
- In the past 5 years, Astria Therapeutics' Other Gross PP&E Adjustments registered a high of $1.7 million during Q4 2017, and its lowest value of -$1.4 million during Q3 2019.
- In the last 3 years, Astria Therapeutics' Other Gross PP&E Adjustments had a median value of -$201,000 in 2017 and averaged -$136,545.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 45.59% in 2018, then slumped by 601.04% in 2019.
- Quarterly analysis of 3 years shows Astria Therapeutics' Other Gross PP&E Adjustments stood at $1.7 million in 2017, then slumped by 100.95% to -$16,000 in 2018, then tumbled by 601.04% to -$1.4 million in 2019.
- Its last three reported values are -$1.4 million in Q3 2019, -$291,000 for Q2 2019, and -$346,000 during Q1 2019.